DFW Neuropathy
Have updates for this profile? Please contribute data
= Subscriber Access Only
You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.
With Preqin Pro, you gain an unobstructed view of all alternative asset class activity across institutional investors, fund managers, funds, portfolio companies, deals, exits, and service providers.
DFW Neuropathy - overview
Established
2010
Location
Arlington, TX, US
Primary Industry
Healthcare
About
Based in Texas, US, and founded in 2010, DFW Neuropathy is a health clinic company specializing in the treatment of all types of neuropathies and musculoskeletal pain and ailments. In September 2022, the firm raised an investment led by HCAP Partners, alongside Baymark Partners. The firm, as of October 2022, has four locations in the Dallas-Fort Worth metroplex namely in Frisco, Arlington, Fort Worth-Keller, and Denton, and is led by its founder, President, and CEO, Ali Alavi. The company heals or reverses the peripheral nerve damage caused by diabetes, impact injuries, Osteoarthritis, or medication damage through Combination Electroanalgesia Treatment (CET).
CET mimics nerve signaling and helps the circulation in the extremities of the patient to promote nerve healing, reverse numbness, restore sensation, and improve acuity, balance, and strength in hands and feet. The company also treats musculoskeletal conditions, such as back pain and knee pain. The company plans to use the funding raised in September 2022 to expand its footprint and accelerate its plans to serve a wider patient population.
Current Investors
HCAP Partners, Baymark Partners
Primary Industry
Healthcare
Sub Industries
Clinics/Outpatient Services, Healthcare Specialists
Website
www.dfwneuropathy.com
Company Stage
Mature - Growth Capital
Total Amount Raised
Subscriber access only
DFW Neuropathy - deals
| Deals Type | Deal Status | Target (s) | Deal Date | Investor(s) | Seller(s) | Deal size (Mn) | Enterprise value (Mn) | Post-money valuation (Mn) | EBITDA multiple (x) | Revenue multiple (x) | Lead partner (s) |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Growth | Completed | DFW Neuropathy | - |
Displaying 1 - 1 of 1
Time to go Pro
Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.